Resolutions from the annual shareholders’ meeting 2024

Today an ordinary shareholders’ meeting was conducted. The following resolutions were made: •  Approval of the audited Annual Report for 2023 •  Approval of distribution of profit with payment of an ordinary dividend of DKK 2.00 or EUR 0.27 per A/B share of DKK 2 for the last four months (September 1 - December 31) of 2023. Legacy Novozymes shareholders will then have received a total pay-out of the 2023 adjusted net profit of DKK 6.20 per share, which equals an increase of 3% compared with 2022. •  Approval of the Remuneration Report for 2023 •  Approval of the remuneration of members of the Board of Directors •  Re-election of Cornelis (Cees) de Jong as Chair and Jesper Brandgaard as Vice Chair of the Board of Directors •  Re-election of Heine Dalsgaard, Sharon James, Kasim Kutay, Lise Kaae, Kevin Lane, Morten Sommer and Kim Stratton as members of the Board of Directors •  Election of EY Godkendt Revisionspartnerselskab as the company’s auditors in respect of statutory financial and sustainability reporting •  Approval to renew authorizations to the Board of Directors to implement capital increases •  Approval to renew the authorization to the Board of Directors to acquire treasury shares •  Approval of authorization to the Board of Directors to distribute extraordinary dividends •  Approval of amendments to the Articles of Association •  Approval of amendments to the Remuneration Policy Following the annual shareholders’ meeting, the Board of Directors consists of the following members: •  Cornelis (Cees) de Jong, Chair •  Jesper Brandgaard, Vice Chair •  Heine Dalsgaard •  Sharon James •  Kasim Kutay •  Lise Kaae •  Kevin Lane •  Morten Sommer •  Kim Stratton Employee representatives: •  Anne Breum •  Anders Hentze Knudsen •  Preben Nielsen •  Jens Øbro •  Karen Louise Lauesen, observer •  Kim Ib Sørensen, observer For further information on members of the Board of Directors, please go to www.novonesis.com

Attachment

• 2024_14_AGM_Resolutions